LRRK2G2019S as a Cause of Parkinson's Disease in North African Arabs
Top Cited Papers
- 26 January 2006
- journal article
- letter
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 354 (4), 422-423
- https://doi.org/10.1056/nejmc055540
Abstract
Parkinson's disease is characterized by resting tremor, rigidity, and bradykinesia caused by the loss of dopaminergic neurons in the substantia nigra, a good response to levodopa, and the presence of Lewy bodies. The recently identified G2019S mutation in exon 41 of the leucine-rich repeat kinase 2 gene (LRRK2) accounts for 2 to 6 percent of familial and 1 to 2 percent of sporadic cases.1 The mutation is less common in Asian populations1 but prevalent in patients from North Africa who have Parkinson's disease, as we describe here.Keywords
This publication has 8 references indexed in Scilit:
- LRRK2G2019S as a Cause of Parkinson's Disease in Ashkenazi JewsNew England Journal of Medicine, 2006
- Genetics of Parkinson's disease: LRRK2 on the riseBrain, 2005
- Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activityProceedings of the National Academy of Sciences, 2005
- G2019S LRRK2 mutation in French and North African families with Parkinson's diseaseAnnals of Neurology, 2005
- LRRK2 gene in Parkinson diseaseNeurology, 2005
- LRRK2 Haplotype Analyses in European and North African Families with Parkinson Disease: A Common Founder for the G2019S Mutation Dating from the 13th CenturyAmerican Journal of Human Genetics, 2005
- Identification of a Novel LRRK2 Mutation Linked to Autosomal Dominant Parkinsonism: Evidence of a Common Founder across European PopulationsAmerican Journal of Human Genetics, 2005
- Association between Early-Onset Parkinson's Disease and Mutations in theParkinGeneNew England Journal of Medicine, 2000